Alloy Therapeutics vs BioLegend

Alloy Therapeutics vs BioLegend, compared side by side on 10 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alloy Therapeutics is on 51/100 and BioLegend on Not scored yet.

Alloy Therapeutics logo
Alloy TherapeuticsA biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.
Try Alloy Therapeutics
BioLegendDeveloper and manufacturer of antibodies and reagents for biomedical research.
Try BioLegend

Where each one leads

Alloy Therapeutics

Leads on none of the measures we hold for both companies.

BioLegend

  • agent readiness: 51/100 against 39/100
  • domain rating: 65/100 against 47/100

At a glance

MeasureAlloy TherapeuticsBioLegend
What it isA biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.Developer and manufacturer of antibodies and reagents for biomedical research.
CategoryBiotechnology, Artificial Intelligence, Drug Discovery, Drug DevelopmentBiotechnology, Life Sciences, Discovery Tools, Antibodies
Sells toBusiness modelB2BB2B
OfferingPlatformSoftware | hardware | services | marketplace | platform
Founded20172002
HeadquartersBoston, USASan Diego, United States
StatusActiveActive

Size, funding and growth

MeasureAlloy TherapeuticsBioLegend
EmployeesNot published660
Total funding$157MNot published
Latest roundSeries ENot published
Valuation$1.0BNot published
LinkedIn followersNot published27,014

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAlloy TherapeuticsBioLegend
StartupHub scoreOur 0-100 rating51/100Not published
Traction40/100Not published
Team30/100Not published
Search visibility15/100Not published
Quality68/100Not published
Agent readinessHow well an AI agent can read and act on the siteF (39/100)D (51/100)
Domain ratingLink authority, 0-10047/10065/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAlloy TherapeuticsBioLegend
CDNCloudflareCloudflare
CMSWordPressNot detected
FrameworksJqueryNot detected
AnalyticsGoogle Tag ManagerNot detected
Support stackHubSpotNot detected

Alloy Therapeutics vs BioLegend: common questions

Which is better, Alloy Therapeutics or BioLegend?

On our 0-100 score Alloy Therapeutics rates higher (51/100 against Not scored yet). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 10 data points above: read the rows that match what you are buying for.

How do Alloy Therapeutics and BioLegend compare on the numbers?

BioLegend leads on agent readiness (51/100 against 39/100), domain rating (65/100 against 47/100).

Read the full Alloy Therapeutics review and pricing or the BioLegend review and pricing. You can also browse other Alloy Therapeutics alternatives we track.